94413 ⎘
Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms; Nitrogen atoms not forming part of a nitro radical with hetero atoms directly attached to said nitrogen atoms
METHODS AND COMPOSITIONS FOR TREATING CANCER
#2Manufacturing process for 2-nitroimino heterocyclic compounds
#3Therapeutic compounds
#4Inhibitors of creatine transport and uses thereof
#5Substituted guanidines as fungicides
#6Inhibitors of creatine transport and uses thereof
#7Hydrazinyl lipidoids and uses thereof
#8CETP Inhibitors
#9Benzimidazole derivatives useful TRPM8 channel modulators
#10Benzimidazole derivatives useful as TRPM8 channel modulators
#11Novel Compounds
#12Benzimidazole derivatives useful as TRPM8 channel modulators
#13Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
#14CETP inhibitors
#15Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient
#16DIAMINE DERIVATIVE
#172-imidazolines
#18Kinase inhibitors, compositions thereof, and methods of use therewith
#19Cetp Inhibitors
#20Compounds
#21Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient
#22CETP inhibitors
#231-(4-bromobenzylideneamino)-5-phenylimidazolidine-2,4-dione as an antimicrobial compound